Increased primaquine total dose prevents Plasmodium vivax relapses in patients with impaired CYP2D6 activity: report of three cases

Pina-Costa, Anielle de; Silvino, Ana Carolina Rios; Santos, Edwiges Motta dos; Pedro, Renata Saraiva; Moreira, José; Umana, Gabriela Liseth; Silva, Ana Danielle Tavares da; Santos, Otília Helena Lupi da Rosa; Henriques, Karina Medeiros de Deus; Daniel-Ribeiro, Cláudio Tadeu; Brasil, Patrícia; Sousa, Tais Nobrega; Siqueira, André M..
Artículo en Inglés | ARCA | ID: arc-49680

Documentos relacionados

  1. [Effectiveness and tolerance of a new molecule with secreto-dynamic activity: nesosteine].
  2. [Clinical study of a preparation with bronchomucotropic activity: guacetisal].
  3. [Raised creatine-kinase serum activity: not necessarily a sign of disease].
  4. [Retroperitoneal dedifferentiated liposarcoma (DDLS) with hyperglycemic activity: case report and literature review].
  5. [Serum gamma-glutamyltransferase activity: a new marker for coronary artery bypass graft disease].
  6. [A Systematic Review of Reviews of Interventions for the Promotion of Physical Activity: Methodology and First Results].
  7. [Fields of increased activity: the electrophysiological correlates].
  8. [Physical activity: results of the German Health Interview and Examination Survey for Adults (DEGS1)].
  9. [Rehabilitation counselors' vocational fields of activity: empirical findings of an exploratory study in Germany].
  10. [Effect of ceruloplasmin conformation on its activity: significance for clinical analysis].